Novartis Ties Bond Sale to Malaria Treatment Access in Sustainability Push Novartis Ties Bond Sale to Malaria Treatment Access in Sustainability Push

Novartis raised 1.85 billion euros on Wednesday from the sale of a bond on which interest payments will rise if the drugmaker fails to expand access to medicines and programmes to combat malaria and leprosy.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news